http://www.onemedplace.com/blog/wp-content/uploads/2010/07/handshake2.jpg
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/07/nyc-sea-in-the-ski...
The mid-year conference's goal was to bring together a promising group of 75 private and microcap companies in 25 different healthcare sectors with a prominent group of European and U.S. institutional...
View Article
More Pages to Explore .....
